Peptide Package Held by Customs? What an FDA Detention Notice Means

The short answer

If a peptide shipped from abroad was held, you will typically receive a Notice of FDA Action marked "Detained" or "Detained/May be Destroyed." It means FDA thinks the product appears to violate U.S. law, most often as an unapproved new drug, and it gives you a chance to present evidence otherwise. FDA's import pages say the notice generally gives 20 calendar days from the date of detention to respond. If you don't respond, or your evidence doesn't overcome the apparent violation, the product is refused and either returned to the sender or, for some drug shipments, destroyed.

For most research-labeled peptides ordered from overseas sellers, the realistic outcome is that the parcel does not arrive. This guide explains why, what the notice means, and what you can reasonably do. It is general information, not legal advice; if you have broader legal concerns, talk to a lawyer.

How a parcel ends up detained

According to FDA, packages arriving by international mail are routed by the U.S. Postal Service to U.S. Customs and Border Protection. CBP refers FDA-regulated products to FDA investigators, who examine them at one of eight international mail facilities: in Florida, Hawaii, Illinois, New Jersey, New York, California, Puerto Rico and the U.S. Virgin Islands. Packages suspected of containing controlled substances go back to CBP for its own determination.

If a package appears to violate FDA law and does not meet the definition of a personal importation that FDA will allow, it may be detained. FDA lists the grounds for detention as products that appear to be adulterated, misbranded, an unapproved new drug, made under insanitary conditions, or forbidden for sale in the country where they were produced.

Peptides marketed for human use without FDA approval fit the "unapproved new drug" description. A "research use only" label does not change that analysis when the surrounding marketing points to human use, as FDA's August 2026 warning letters to peptide vendors showed. Our overview of where peptide legality actually stands and the FDA peptide status tracker give the current regulatory picture.

What the Notice of FDA Action says

FDA's detention-and-hearing page explains that a notice marked "Detained" is considered the Notice of Detention and Hearing. The "hearing" is not a courtroom; it is your opportunity to present oral or written testimony to FDA to overcome the appearance of a violation. Testimony goes to the contact named on the notice, usually a compliance officer.

The response window

FDA says its Regulatory Procedures Manual allows 10 business days from the date of detention, while the Notice of FDA Action generally specifies 20 calendar days. Use the date on your notice. FDA also says extensions are possible if you request one within the stated timeframe and give a reasonable basis.

Possible outcomes

• Released: if your evidence shows the product complies, FDA issues a notice that the product has been released and the package continues to you.
• Refused: if no timely response is received, or the evidence is not enough, the product is refused admission. The refusal notice states the reasons.
• Destroyed or returned: for some refused drugs and devices, FDA uses its administrative destruction authority. The notice says whether the product will be destroyed or returned to the sender. Other refused products are returned through USPS.

The personal importation policy, and why it rarely helps here

FDA's personal importation page starts with the general rule: in most circumstances it is illegal for individuals to import drugs into the U.S. for personal use, including drugs approved in another country that are unapproved here.

FDA describes a narrow enforcement-discretion policy in which staff may make a more permissive decision. For a product treating a serious condition, the conditions FDA lists include:

• effective treatment may not be available domestically,
• there is no known commercialization or promotion of the product to people in the U.S.,
• the product does not represent an unreasonable risk,
• you affirm in writing that it is for your own use,
• the quantity is generally not more than a three-month supply,
• you provide the name and address of a U.S.-licensed doctor treating you, or evidence that the product continues treatment begun abroad.

Research-labeled peptides sold online to U.S. buyers rarely fit. They are, by design, promoted to people in the U.S.; there is typically no U.S. doctor overseeing their use; and FDA has not determined they pose no unreasonable risk. The policy exists for people continuing a specific foreign treatment, not for ordering chemicals from a website. Our international peptide access guide covers how other countries handle the same products.

Your realistic options

A few practical points. Keep the notice and your order records. Do not try to re-route the same product through another address or courier. If the seller pressures you to "just order again," that tells you their business model depends on some parcels slipping through. Whatever you decide, don't send more money to an overseas seller on the promise of a reship until you understand why the first parcel was held.

If you need a peptide for a medical reason, the legal route goes through a prescriber and a licensed pharmacy. Our guide on how to get peptides prescribed lays it out, and this supply-chain comparison explains why domestic research vendors, compounding pharmacies and FDA-approved drugs are different categories.

Domestic research vendors and travel

Some laboratory buyers move to U.S.-based research suppliers to avoid international mail entirely. That avoids the import process, but it does not change the product category: research-use-only products are not sold for human use. Compare suppliers on lot-matched COAs and stated policies; these are suppliers we compare on published COAs and policies, and we do not lab-test products.

If you are carrying a prescribed peptide across borders yourself rather than shipping it, different rules apply. Our guide to traveling with peptides covers TSA screening and international considerations. And if a domestic order does reach you, run through our arrival inspection checklist before storing it.

Keep the notice with your order records. If you ask an overseas seller for a refund, the notice is your evidence that the parcel was held at the border rather than lost or never sent.

For contact with FDA about an import notice, FDA lists 1-888-INFO-FDA (1-888-463-6332), but the fastest route is usually the compliance officer named on your notice.